Stock Events

Coloplast AS 

$130.85
146
+$3.04+2.38% Thursday 20:00

Statistics

Day High
121.99
Day Low
121
52W High
143.15
52W Low
99.78
Volume
784
Avg. Volume
1,367
Mkt Cap
25.42B
P/E Ratio
0
Dividend Yield
2.32%
Dividend
3.03

Upcoming

Dividends

2.32%Dividend Yield
10Y Growth
3.9%
5Y Growth
-1.85%
3Y Growth
0.98%
1Y Growth
-0.22%

Earnings

7MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0
0.27
0.55
0.82
Expected EPS
N/A
Actual EPS
0.08

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLPBF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap18.01B
Baxter International Inc. offers a range of medical devices and services that compete directly with Coloplast's offerings in the continence and critical care sectors.
Medtronic
MDT
Mkt Cap101.91B
Medtronic plc provides medical devices and technologies in areas overlapping with Coloplast's, including urology and pelvic health.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific Corporation competes in the medical devices sector, particularly in areas of urology and pelvic health, similar to Coloplast.
Hologic
HOLX
Mkt Cap18.23B
Hologic, Inc. is involved in women's health, diagnostics, and surgical products, competing with Coloplast in the healthcare solutions sector.
Smith & Nephew
SNN
Mkt Cap12.37B
Smith & Nephew plc provides advanced wound care, orthopedics, and other medical devices, competing with Coloplast in the wound care market.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson operates in the healthcare sector, offering products through its medical devices division that compete with Coloplast's offerings in wound care and surgery.
IQ Healthy Hearts
HART
Mkt Cap9.45M
Hartmann Group focuses on wound management, incontinence management, and infection management, directly competing with Coloplast in these healthcare areas.
Cooper Companies
COO
Mkt Cap18.07B
The Cooper Companies, Inc. is focused on contact lens and women's health, indirectly competing with Coloplast in the healthcare market.
Procter & Gamble
PG
Mkt Cap396.41B
Procter & Gamble Co., through its healthcare segment, offers products that can compete with Coloplast, especially in the personal healthcare and incontinence product lines.
Stryker
SYK
Mkt Cap129.88B
Stryker Corporation is a medical technologies firm with products in orthopaedics, surgery, and neurotechnology, indirectly competing with Coloplast in the healthcare solutions sector.

About

Medical Specialties
Health Technology
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
CEO
Kristian Villumsen
Employees
15930
Country
DK
ISIN
DK0060448595
WKN
000A1KAGC

Listings